Pilot trial encourages further study of intracorneal lens

Trois Rivieres, Quebec-Early limited experience with an intracorneal hydrogel inlay (PermaVision, Anamed Inc., Lake Forest, CA) indicates this synthetic keratophakic implant offers a promising new method for the treatment of hyperopia, said Francis F. Roy, MD.

Related Videos

Related Content

Advertisement

March 21st 2025

Iantrek announces positive 2-year results from clinical study of its bio-interventional platform for uveoscleral outflow enhancement

December 13th 2024

California dreaming: 2025 Glaucoma 360 brings celebration, innovation, and education to San Francisco

March 20th 2025

Ocugen to move forward with dosing of second cohort of phase 1 clinical trial of OCU200

November 19th 2024

Connect, learn, and innovate in a family-friendly atmosphere: What to expect at EnVision Summit 2025

March 20th 2025

Stem cell-based CALEC therapy achieves 90% corneal surface restoration in clinical trial

March 19th 2025

Investigators highlight the risk of misdiagnosing geographic atrophy

Related Content

Advertisement

March 21st 2025

Iantrek announces positive 2-year results from clinical study of its bio-interventional platform for uveoscleral outflow enhancement

December 13th 2024

California dreaming: 2025 Glaucoma 360 brings celebration, innovation, and education to San Francisco

March 20th 2025

Ocugen to move forward with dosing of second cohort of phase 1 clinical trial of OCU200

November 19th 2024

Connect, learn, and innovate in a family-friendly atmosphere: What to expect at EnVision Summit 2025

March 20th 2025

Stem cell-based CALEC therapy achieves 90% corneal surface restoration in clinical trial

March 19th 2025

Investigators highlight the risk of misdiagnosing geographic atrophy